You are here

  • Home
  • Archive
  • Volume 16, Issue 3
  • Pemetrexed (Alimta®, LY231514) demonstrates clinical activity in chemonaive patients with cervical cancer in a phase II single-agent trial

Article info

Article menu
Download PDFPDF
ORIGINAL ARTICLE
Pemetrexed (Alimta®, LY231514) demonstrates clinical activity in chemonaive patients with cervical cancer in a phase II single-agent trial

Authors

  1. Address correspondence and reprint requests to: Louis Goedhals, Department of Oncotherapy, National Hospital, P.O. Box 20598, Private Bay, Bloemfontein X20598, South Africa. Email: goedhall{at}doh.ofs.gov.za

Citation

Goedhals L, Van Wiyk AL, Smith BL, et al
Pemetrexed (Alimta®, LY231514) demonstrates clinical activity in chemonaive patients with cervical cancer in a phase II single-agent trial
International Journal of Gynecologic Cancer 2006;16:1172-1178.

Publication history

  • First published April 1, 2006.
Online issue publication 
April 01, 2006

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2006 Blackwell Publishing Ltd.